Hybrid Breast Augmentation: Implants with Fat

Patient Overview

• Patient: Alev

• Age: 36 years old

• Gender: Female

• Procedures: Hybrid breast augmentation (subfascial silicone implants with fat grafting)

• After photos taken at: 6 months post-surgery

• Location: Istanbul, Turkey

What Hybrid Breast Augmentation Means

Hybrid breast augmentation is a technique that combines two fundamentally different approaches to breast enhancement within a single operation: silicone implants provide the core volume and projection, while autologous fat grafting refines the contour, softens transitions, and adds a layer of natural tissue coverage that no implant alone can replicate. The term "hybrid" reflects this fusion of technologies — implant-based structure married to fat-based finesse — producing a result that draws on the strengths of each while compensating for the limitations of the other.

Alev, a thirty-six-year-old patient of Dr. Cem Berkay Sinaci, underwent hybrid breast augmentation with subfascial implant placement and targeted fat grafting. Her six-month photographs represent the definitive outcome of this combined approach — a result where the implant provides the volume she desired and the fat provides the natural tissue quality that makes the augmentation virtually undetectable.

Dr. Sinaci, a European board-certified plastic surgeon (FEBOPRAS) and active member of ISAPS and ASPS, has incorporated hybrid breast augmentation into his practice for patients whose anatomy benefits from the additional refinement that fat grafting provides beyond what implant placement alone can achieve.

Why Implants Alone Sometimes Fall Short

Silicone implants are remarkably effective at adding volume, projection, and shape to the breast. But they are manufactured objects with defined edges, uniform surfaces, and predictable geometry. In patients with thin soft tissue coverage — whether from naturally lean body composition, low body fat percentage, or age-related tissue thinning — these manufactured characteristics can become visible or palpable through the skin.

The upper pole and medial border of the breast are the areas where implant detectability is highest. The tissue between the implant and the skin surface is thinnest in these regions, and in lean patients, the implant edge can create a visible step-off where the device ends and the natural chest wall begins. Rippling — the visible wrinkling of the implant shell through thin skin — is another concern in patients with insufficient soft tissue coverage.

Traditional solutions to these problems include selecting a smaller implant, choosing submuscular placement for additional muscle coverage, or accepting that some degree of implant visibility is an unavoidable trade-off. Hybrid breast augmentation introduces a fourth option: adding a living layer of the patient's own fat over the implant in areas where coverage is deficient.

For Alev at thirty-six, the fat grafting component addressed precisely these vulnerable zones, adding biological tissue thickness where her natural coverage was thinnest and creating a seamless transition between implant and chest wall that no surgical plane alone could achieve.

How the Two Techniques Work Together

The hybrid breast augmentation procedure follows a carefully sequenced approach. The implant placement is performed first, establishing the core volume and shape of the breast. In Alev's case, subfascial placement positioned the implant above the pectoralis muscle but beneath its fascial envelope, creating the natural movement and unified tissue behaviour that the subfascial plane provides.

Once the implant is seated and the pocket is closed, the fat grafting component begins. Fat is harvested from a donor site — typically the abdomen, flanks, or thighs — using gentle liposuction techniques that preserve fat cell viability. The harvested fat is processed to separate viable adipocytes from oil, blood, and infiltration fluid. The purified fat is then injected in small, precisely placed deposits over and around the implant in the areas identified during preoperative planning as needing additional coverage.

The fat is distributed in multiple thin layers rather than a single large bolus. This technique maximises the percentage of transferred fat cells that will survive by ensuring that each cell sits within diffusion distance of a blood supply. Fat cells that are too far from capillaries cannot receive oxygen and nutrients, leading to reabsorption. The meticulous, layered injection technique that Dr. Sinaci employs — refined through his fellowship with the internationally renowned plastic surgeon Raul Gonzalez in Brazil, where fat grafting techniques have been pioneered and perfected over decades — maximises graft survival and produces predictable, lasting volume.

The Subfascial Choice in Hybrid Augmentation

The selection of the subfascial plane for Alev's implant component was a deliberate decision that complements the hybrid approach. In subfascial placement, the implant sits above the muscle, which means the fat grafting layer is applied over the implant with only the fascia and breast tissue intervening. This creates a straightforward anatomical arrangement: chest wall, muscle, fascia, implant, fat graft, breast tissue, skin. Each layer contributes to the overall coverage and naturalness of the result.

Had the implant been placed under the muscle, the fat grafting would still be applied superficially, but the muscle between the implant and the fat graft would create a more complex layered arrangement. The subfascial plane simplifies the anatomical relationship between implant and fat, allowing the grafted tissue to integrate directly over the implant surface where it provides the most benefit.

Additionally, the subfascial plane allows the implant and the grafted fat to exist in the same tissue compartment, meaning they move together as the breast changes position. This unity of movement — implant, fat, and breast gland all shifting as one structure — is what produces the natural dynamic quality that distinguishes hybrid breast augmentation from implant-only results.

Six Months: The True Hybrid Result

Alev's six-month photographs capture the hybrid breast augmentation at its definitive endpoint. Both components of the procedure have reached their final state.

The subfascial implant has been fully settled for months. The pocket has matured, the capsule has stabilised, and the breast shape reflects the permanent configuration of the implant within its tissue environment. The breast moves naturally, sits proportionally on the chest wall, and shows none of the animation deformity that submuscular placement can produce.

The fat graft has completed its biological journey. The revascularisation process that determines which transferred fat cells survive and which are reabsorbed is fully concluded by three months. The volume that Alev's fat graft shows at six months is permanent — these cells have established their blood supply, integrated into the surrounding tissue, and become a living, lasting component of her breast soft tissue coverage.

The combined effect is a breast that feels more natural to the touch than an implant-only augmentation. The grafted fat layer between the implant and the skin surface softens the tactile quality of the breast, reducing or eliminating the palpability of the implant edge. Visually, the transitions between augmented breast and natural chest wall are seamless — no visible step-offs, no rippling, no telltale signs that an implant is present beneath the surface.

Who Benefits Most from Hybrid Breast Augmentation

Hybrid breast augmentation is not necessary for every patient. Women with adequate natural soft tissue coverage may achieve excellent results with implants alone, and adding fat grafting would introduce unnecessary complexity without meaningful benefit. The technique is most valuable in specific clinical scenarios.

Patients with thin tissue coverage who desire implant augmentation but are concerned about implant visibility benefit from the additional camouflage layer that fat grafting provides. Patients with mild contour irregularities in the chest wall or breast that an implant alone cannot smooth find that fat grafting addresses these localised deficits. Patients who want the maximum degree of naturalness in both appearance and feel — where even the possibility of palpating an implant edge is unacceptable — gain measurable improvement from the hybrid approach.

Alev's case at thirty-six placed her in this last category. Her goal was augmentation that would be completely undetectable by sight or touch, and the combination of subfascial implant placement with targeted fat grafting delivered exactly this outcome.

The Additional Benefit: Body Contouring at the Donor Site

An often underappreciated advantage of hybrid breast augmentation is the secondary benefit at the fat harvesting site. The liposuction required to collect fat for grafting removes adipose tissue from an area where the patient typically has unwanted excess. The abdomen, flanks, or thighs become slimmer as a result of the harvest, producing a body contouring effect that complements the breast enhancement.

For Alev, this meant that a single surgical session addressed two aesthetic goals: fuller, more natural breasts and a more refined contour at the donor site. This efficiency — achieving two improvements through one recovery period — is a practical advantage that hybrid breast augmentation offers over implant-only procedures.

Hybrid Breast Augmentation in Istanbul

Alev's six-month before and after result demonstrates the refinement that hybrid breast augmentation brings to implant-based enhancement. The combination of subfascial silicone implants for core volume with autologous fat grafting for tissue quality and contour produces a result that neither technique could achieve independently. For patients researching breast augmentation in Istanbul who prioritise naturalness above all other goals, understanding that hybrid breast augmentation exists as an option — and that it combines the proven reliability of implants with the biological integration of the patient's own tissue — opens the door to a level of result that implants alone may not deliver for every anatomy.